Login / Signup

Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials.

Linda G MellbinDeepak L BhattJens-Peter DavidKathrine EkströmMark C PetrieSøren RasmussenTina Vilsbøll
Published in: European heart journal (2024)
Keyphrases
  • type diabetes
  • cardiovascular disease
  • glycemic control
  • adipose tissue
  • metabolic syndrome
  • skeletal muscle